StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research report report published on Monday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
NASDAQ:CALA opened at $0.01 on Monday. The firm’s fifty day simple moving average is $0.02 and its 200 day simple moving average is $0.02. Calithera Biosciences has a twelve month low of $0.01 and a twelve month high of $0.13.
About Calithera Biosciences
Featured Articles
- Five stocks we like better than Calithera Biosciences
- What Investors Need to Know About Upcoming IPOs
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- How is Compound Interest Calculated?
- Jeff Brown’s Exegesis AI Stock Picks
- The 3 Best Retail Stocks to Shop for in August
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.